New/Updated Guidelines

|

An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases

These evidence-based guidelines are developed and updated regularly by a committee of hepatology experts and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.

You will need Adobe Acrobat Reader to view these documents.

Also: Visit the National Guideline Clearinghouse to read the summary version

Download fulltext and summary versions to the following devices:

Expand for Details

Guideline

Date

Scheduled Update

Source

Author

Expand for Details : Acute liver failure, management ‎(1)

Expand for Details : Hemochromatosis, management ‎(1)

Expand for Details : Hepatitis C, management and treatment ‎(1)

AASLD strives to review and update its Practice Guidelines every five (5) years, as necessary. Users are cautioned that in the interim, scientific and medical developments may supercede or invalidate, in whole or in part, specific recommendations in any Guideline. A Guideline is considered to be "inactive" if it has not been updated by AASLD in at least five (5) years, and for this reason particular care must be exercised in placing reliance on an inactive Guideline.

Guidelines Development

AASLD does not accept corporate support for the development of practice guidelines. However, AASLD gratefully acknowledges the support of Genentech and Merck for providing independent medical education grants for mobile download applications for AASLD practice guidelines.

New/Updated Guidelines var addthis_options = 'facebook, digg, delicious, linkedin, twitter, more';var addthis_exclude = 'print'; |

New/Updated Guidelines

|